Table 1 Different criteria for diagnosing metabolic syndrome (MetS) used in studies included in this review
Criteria | Study | Men | Women | |
|---|---|---|---|---|
Waist | IDF[22] | Pasalic et al., 2011[14] | ≥ 94 cm | ≥ 80 cm |
IDF[17] | Ramel et al., 2009[10] | |||
JIS[2] | Zaribaf et al., 2014[16] | |||
ATP III[20] | Kouki et al., 2011[12] | > 102 cm | > 88 cm | |
ATP III[21] | Lai et al., 2013[13] | |||
ATP III[20] | Ruidavets et al., 2007[15] | |||
Alternative[19] | Baik et al., 2010[11] | ≥ 85 cm | ≥ 80 cm | |
S-HDL cholesterol | ATP III[18] | Baik et al., 2010[11] | < 1.0 mmol/L (40 mg/dL) | < 1.3 mmol/L (50 mg/dL) |
ATP III[20] | Kouki et al., 2011[12] | |||
ATP III[21] | Lai et al., 2013[13] | |||
IDF[22] | Pasalic et al., 2011[14] | |||
IDF[17] | Ramel et al., 2009[10] | |||
ATP III[20] | Ruidavets et al., 2007[15] | |||
JIS[2] | Zaribaf et al., 2014[16] | |||
S-triglyceride | ATP III[18] | Baik et al., 2010[11] | ||
ATP III[20] | Kouki et al., 2011[12] | |||
ATP III[21] | Lai et al., 2013[13] | |||
IDF[22] | Pasalic et al., 2011[14] | > 1.7 mmol/L (150 mg/dL) | ||
IDF[17] | Ramel et al., 2009[10] | |||
ATP III[20] | Ruidavets et al., 2007[15] | |||
JIS[2] | Zaribaf et al., 2014[16] | |||
Blood pressure | ATP III[18] | Baik et al., 2010[11] | ||
ATP III[20] | Kouki et al., 2011[12] | |||
ATP III[21] | Lai et al., 2013[13] | |||
IDF[22] | Pasalic et al., 2011[14] | SBP ≥130 mm Hg | ||
IDF[17] | Ramel et al., 2009[10] | DBP ≥85 mm Hg | ||
ATP III[20] | Ruidavets et al., 2007[15] | |||
JIS[2] | Zaribaf et al., 2014[16] | |||
Fasting S-glucose | ATP III[18] | Baik et al., 2010[11] | ≥ 5.6 mmol/ L (100 mg/dL) | |
IDF[22] | Pasalic et al., 2011[14] | |||
IDF[17] | Ramel et al., 2009[10] | |||
JIS[2] | Zaribaf et al., 2014[16] | |||
ATP III[20] | Kouki et al., 2011[12] | ≥ 6.1 mmol/l (110 mg/dL) | ||
ATP III[21] | Lai et al., 2013[13] | |||
ATP III[20] | Ruidavets et al., 2007[15] | |||